Skip to main content

Find Clinical Trials

Home
Conditions
Mast Cell Activation Disorders

Clinical trial condition

Mast Cell Activation Disorders

Explore clinical trials studying Mast Cell Activation Disorders. Study availability and eligibility vary by location and protocol.

93 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Mast Cell Activation Disorders trial results

Active, Not Recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

NCT03731260

Conditions: Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Hospital Phoenix, Arizona, United States

Stanford Cancer Institute Stanford, California, United States

Mayo Clinic Florida Jacksonville, Florida, United States

View all 49 locations

View Trial Details

Active, Not Recruiting

Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis

NCT06065007

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +5 more
Locations: Karolinska Institutet Stockholm, Sweden

Uppsala University Uppsala, Sweden

View Trial Details